Exact Sciences Corp
(NAS:EXAS)
$
54.69
-0.03 (-0.05%)
Market Cap: 10.12 Bil
Enterprise Value: 11.77 Bil
PE Ratio: 0
PB Ratio: 3.15
GF Score: 80/100 Exact Sciences Corp at Piper Sandler Healthcare Conference Transcript
Nov 28, 2023 / 07:00PM GMT
Release Date Price:
$64.97
(-1.29%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
All right. Thank you, everybody, for joining us. I'm here with CEO, Kevin Conroy; and CCO, Everett Cunningham.
So I'll just start off with saying -- oh, and I'm David Westenberg, the diagnostics analyst.
Questions & Answers
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst
You came up a lot of consecutive beat-and-raise quarter, where operating margins, frankly, probably surprised even you guys. As we approach the tough comps, how should we think about the momentum in the business, and what your potential is to beat expectations?
Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO
Not a lot surprises to us about our business (inaudible). Thanks for having us. We are really happy to be back at the Piper Conference, and Dave, our business continues to grow. It's a strong business, and it starts with our lead colon
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot